Testing a pulse field therapy for reduced heart ischemia
Part of Heart & circulation clinical trials.
This trial studies whether pulse electromagnetic field therapy can improve signs of reduced blood flow to the heart (ischemia) in people who cannot or will not get a coronary procedure during the study. If you already take standard heart medicines, you may be eligible to add this therapy and undergo exercise testing and heart imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older.
- You have known heart ischemia and cannot or will not have a coronary procedure during the study (like stents or other interventions).
- Past tests (like an echocardiogram, nuclear scan, or a standard ECG in the last 6 months) showed ischemia.
- Your heart pumping strength is preserved: left ventricular ejection fraction over 40% on an echo done in the last 3 months.
- You can do a supervised exercise test, and any limits are not mainly from orthopedic problems (like severe joint issues).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This trial tests two types of high-intensity pulsed electromagnetic field therapy (one using two modes, another using one mode) to see if they can reduce pain and improve function in older adults with knee osteoarthritis. You would attend 9 treatment sessions and do exercises at home.
This trial tests whether pulsed electromagnetic field therapy can improve how well athletes perform and recover. It may help if you are an active person who works out regularly and competes in events.
This trial tests whether pulsed electromagnetic fields can help prevent muscle loss and weakness in patients with blood cancer who are in the hospital for a long time. It is for patients starting chemotherapy for acute leukemia or getting a stem cell transplant.
This trial tests whether daily, long-term use of pulsed electromagnetic fields applied to the head can help reduce Parkinson's symptoms. It is for people with mild to moderate Parkinson's who are not on certain blood thinners and have no major health complications like other neurological diseases or active implants.
This study tests whether a pulsed electromagnetic field (PEMF) device can help people with mild to moderate Alzheimer's or related dementias. If you or a loved one has memory loss, this trial looks at a potential new way to support brain health without medication.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.